GlassScriptPhysician profile
Benjamin B Bedford
NPI 1124260799
$74,524.78
in general payments reported to CMS, 2019-2025
36 companies · $7,431 in 2025
The $7,431 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,513 · 2021: $13K · 2022: $6,791 · 2023: $30K · 2024: $5,000 · 2025: $7,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $25K · Food and Beverage: $12K · Travel and Lodging: $6,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $24,978.56 |
| Food and Beverage | $11,768.42 |
| Travel and Lodging | $6,171.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $26,797.11 | 2019-2025 | Tapestry, Juggerknotless Soft Anchor, Comprehensive Shoulder System |
| Arthrex, INC. | $24,227.79 | 2019-2025 | |
| Stryker Corporation | $5,737.76 | 2019-2025 | Alphavent, Variax, T2 Alpha |
| Gotham Surgical Solutions & Devices, INC. | $4,000.46 | 2019-2022 | |
| Suvon Surgical LLC | $2,812.64 | 2023-2025 | |
| Globus Medical, INC. | $1,876.86 | 2022-2025 | Legacy Stelkast Knee, Clavicular Fracture Fixation, Proximal Humerus Strut |
| Polynovo North America LLC | $1,318.82 | 2023-2025 | Novosorb Btm |
| Sanara Medtech INC. | $1,008.18 | 2024 | Celleraterx |
| Depuy Synthes Sales INC. | $834.91 | 2019-2025 | Twistr, Rigidloop, Dynacord |
| Lifenet Health | $758.49 | 2020-2025 | Quadlink, Graftlink, Duallink |
| Djo, LLC | $587.05 | 2021-2025 | Cmf |
| Embody, INC. | $489.69 | 2021-2022 | |
| Bioventus LLC | $453.75 | 2019-2021 | |
| Davol INC. | $316.68 | 2022-2023 | Arista Ah Flexitip |
| Joint Restoration Foundation, INC. | $289.48 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $278.70 | 2019-2020 | |
| Anika Therapeutics, INC. | $274.97 | 2025 | Tactoset, Integrity Implant |
| Orthofix Medical, INC. | $237.39 | 2019-2025 | Physio-Stim |
| Miach Orthopaedics, INC. | $205.88 | 2024 | |
| Arthrosurface Incorporated | $187.71 | 2019 | |
| Orthalign INC | $167.26 | 2025 | Orthalign Plus |
| Becton, Dickinson and Company | $158.02 | 2022 | |
| Lima USA, INC. | $149.68 | 2019 | |
| Skeletal Dynamics INC | $148.07 | 2022 | |
| Linvatec Corporation | $145.61 | 2022 | |
| Smith+Nephew, INC. | $142.30 | 2020 | |
| Kerecis Limited | $141.12 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Heron Therapeutics, INC. | $136.55 | 2021 | |
| Avanos Medical | $131.14 | 2025 | Coolief Cooled Radiofrequency, Trivisc Sodium Hyaluronate |
| Rti Surgical, INC | $128.72 | 2023 | |
| Medline Industries LP | $122.89 | 2019 | |
| Ossio INC | $121.10 | 2023 | |
| Horizon Therapeutics Plc | $64.71 | 2019 | |
| Nevro Corp. | $32.70 | 2022 | |
| Dynasplint Systems INC. | $21.77 | 2024 | Dynasplint |
| Ferring Pharmaceuticals INC. | $18.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$109,035.56 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Bedford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.